Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Distribution of 3H-soman in mice

Abstract

3H-soman (specific activity 10 Ci/mMol), a potent irreversible cholinesterase inhibitor, was administered IV to mice in a dose of one LD-50, which corresponds to 0.25 mCi/mouse. Animals were sacrificed at 5 min, 2 h and 24 h, and whole body autoradiography was performed. High levels of radioactivity in lung and skin were observed at all time intervals after injection. The central nervous system showed very low concentrations of radioactivity, which remained so for 24 h post-injection. Considerable accumulation of 3H-soman in the urine and gallbladder, and in the intestinal lumen, may indicate these as pathways of soman excretion. Quantitative determinations of radioactivity in various tissue samples were consistent with the above-mentioned findings.

It is concluded that the nature of the persistent binding of soman to lung and skin is striking, and may indicate the existence of specific sites for soman depots.

This is a preview of subscription content, log in to check access.

References

  1. Boscovic B (1981) The treatment of soman poisoning and its perspective. Fund Appl Toxicol 1: 203–213

  2. Clement J (1982) Plasma aliesterase — a possible depot for soman (pinacolyl methylphosphofluoridate) in the mouse. Biochem Pharmacol 31: 4085–4088

  3. Ellin RI (1982) Anomalies in the theories and therapy of intoxication by potent organophosphate anticholinesterase compounds. Gen Pharmacol 13: 457–466

  4. Fleisher JH, Harris LW (1965) Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolyl methylphosphofluoridate. Biochem Pharmacol 14: 641–650

  5. Gordon JJ, Leadbeater L, Maidment MP (1978) The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol Appl Pharmacol 43: 207–216

  6. Hansen D, Schaum E, Wasserman O (1968) Serum levels and excretion of diisopropyl fluorophosphate (DFP) in cats. Biochem Pharmacol 17: 1159–1162

  7. Lenz D, Maxwell D, Prather R, Ball L (1983) In vivo determination of 14C-soman in rats. Pharmacologist 25: 111

  8. Niden AH (1967) Bronchiolar and large alveolar cell in pulmonary phospholipid metabolism. Science 158: 1323–1324

  9. Nordgren I, Lundgren G, Puu G, Holmstedt B (1984) Stereoselectivity of enzymes in toxicity and detoxification of soman. Arch Toxicol 55: 70–75

  10. Polak RL, Cohen EM (1969) The influence of triorthocresylphosphate on the distribution of 32P in the body of the rat after the injection of 32P-sarin. Biochem Pharmacol 18: 813–820

  11. Polak RL, Cohen EM (1960) The influence of oximes on the distribution of 32P in the body of the rats after injection of 32P-sarin. Biochem Pharmacol 19: 865–876

  12. Ramachandran BV (1966) Distribution of DF32P in mouse organs I. The effect of route of administration on incorporation and toxicity. Biochem Pharmacol 15: 169–175

  13. Sterri SH, Lyngaas S, Fonnum F (1981) Toxicity of soman after repetitive injections of sublethal doses in guinea-pig and mouse. Acta Pharmacol Toxicol 49: 8–13

  14. Ulberg S (1977) The technique of whole body autoradiography: cryosectioning of large specimens. Science Tools (L.K.B. Instrumental Journal), Special Issue

  15. Weil CS (1952) Tables for convenient calculation of median effective dose (ID 50 or LD 50) and instruction in their use. Biometrics 8: 249–263

  16. Wolthuis OL, Benschop HP, Berends F (1981a) Persistence of the anticholinesterase soman in rats: antagonism with a non-toxic simulor of this organophosphate. Eur J Pharmacol 69: 379–383

  17. Wolthuis OL, Berends F, Meeter E (1981b) Problems in the therapy of soman poisoning. Fund Appl Toxicol 1: 183–192

  18. Yamada S, Isogai M, Okudaira H, Hayashi E (1983) Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine. J Pharmacol Exp Ther 226: 519–525

Download references

Author information

Correspondence to Tamar Kadar.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kadar, T., Raveh, L., Cohen, G. et al. Distribution of 3H-soman in mice. Arch Toxicol 58, 45–49 (1985). https://doi.org/10.1007/BF00292616

Download citation

Key words

  • 3H-soman
  • Anticholinesterase
  • Whole body autoradiography
  • Tissue distribution
  • Drug excretion